10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,728,737 | +53.1% | 156,457 | 0.0% | 3.04% | +53.0% |
| Q4 2022 | $5,701,293 | +29.2% | 156,457 | +1.0% | 1.99% | +6.9% |
| Q3 2022 | $4,413,000 | -37.1% | 154,942 | 0.0% | 1.86% | -43.3% |
| Q2 2022 | $7,011,000 | -40.5% | 154,942 | 0.0% | 3.28% | -27.4% |
| Q1 2022 | $11,786,000 | -48.9% | 154,942 | 0.0% | 4.53% | -43.4% |
| Q4 2021 | $23,080,000 | +2.5% | 154,942 | +0.2% | 8.00% | -1.9% |
| Q3 2021 | $22,507,000 | -18.6% | 154,603 | +9.4% | 8.16% | -18.2% |
| Q2 2021 | $27,661,000 | -3.7% | 141,258 | -11.0% | 9.97% | -14.4% |
| Q1 2021 | $28,735,000 | +20.3% | 158,758 | -5.9% | 11.65% | +13.0% |
| Q4 2020 | $23,896,000 | +17.3% | 168,758 | +3.3% | 10.31% | +6.6% |
| Q3 2020 | $20,368,000 | +15.8% | 163,366 | -17.0% | 9.67% | +8.3% |
| Q2 2020 | $17,589,000 | +36.0% | 196,938 | -5.1% | 8.94% | +16.3% |
| Q1 2020 | $12,936,000 | – | 207,578 | – | 7.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |